Our phosphoproteomic experiments established that exposure of breast tumor cells to SB-699551 curtails Gαi/o signaling and that of the PI3K/AKT/mTOR pathway, lending further evidence of its on-target activity (Supplementary Figure 6). This evidence concerns the gene MTOR and breast neoplasm.